These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 15587908
21. Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Mandelin E, Lassus H, Seppälä M, Leminen A, Gustafsson JA, Cheng G, Bützow R, Koistinen R. Cancer Res; 2003 Oct 01; 63(19):6258-64. PubMed ID: 14559812 [Abstract] [Full Text] [Related]
25. Nucleolar organizer regions in laryngeal cancer. Klatka J, Skomra D. Ann Univ Mariae Curie Sklodowska Med; 2001 Oct 01; 56():417-21. PubMed ID: 11977351 [Abstract] [Full Text] [Related]
26. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma. Morales-Vásquez F, Pedernera E, Reynaga-Obregón J, López-Basave HN, Gómora MJ, Carlón E, Cárdenas S, Silva-Ayala R, Almaraz M, Méndez C. J Ovarian Res; 2016 Jul 07; 9(1):41. PubMed ID: 27388275 [Abstract] [Full Text] [Related]
27. Prognostic significance of nucleolar organizer regions in adenoid cystic carcinomas of the head and neck. Xie X, Nordgård S, Halvorsen TB, Franzen G, Boysen M. Arch Otolaryngol Head Neck Surg; 1997 Jun 07; 123(6):615-20. PubMed ID: 9193223 [Abstract] [Full Text] [Related]
28. Cell kinetic analysis of interleukin-2 receptor-tested chronic lymphocytic leukemia using the AgNOR silver stain. Mourad WA, Pugh WC, Huh YO, Keating MJ. Am J Clin Pathol; 1994 Mar 07; 101(3):300-4. PubMed ID: 8135185 [Abstract] [Full Text] [Related]
33. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience. Bacalbasa N, Balescu I, Dima S, Brasoveanu V, Popescu I. Anticancer Res; 2015 Oct 07; 35(10):5649-54. PubMed ID: 26408738 [Abstract] [Full Text] [Related]
38. [Analysis of prognostic factors for the extent of vascularity of serous ovarian cancer on the basis of CD34 antigen expression]. Blok R, Blok K, Jeleń M, Gryboś M. Ginekol Pol; 2004 Feb 07; 75(2):91-8. PubMed ID: 15108579 [Abstract] [Full Text] [Related]
39. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence]. Tu H, Huang H, Huang QD, Li Z, Feng YL, Liu JH. Zhonghua Fu Chan Ke Za Zhi; 2012 Dec 07; 47(12):928-33. PubMed ID: 23324194 [Abstract] [Full Text] [Related]